Your browser doesn't support javascript.
loading
Tumor-Absorbed Dose Predicts Progression-Free Survival Following (131)I-Tositumomab Radioimmunotherapy.
Dewaraja, Yuni K; Schipper, Matthew J; Shen, Jincheng; Smith, Lauren B; Murgic, Jure; Savas, Hatice; Youssef, Ehab; Regan, Denise; Wilderman, Scott J; Roberson, Peter L; Kaminski, Mark S; Avram, Anca M.
Affiliation
  • Dewaraja YK; Department of Radiology, University of Michigan, Ann Arbor, Michigan yuni@umich.edu.
  • Schipper MJ; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
  • Shen J; Department of Biostatistics, University of Michigan, Ann Arbor, Michigan.
  • Smith LB; Department of Pathology, University of Michigan, Ann Arbor, Michigan.
  • Murgic J; Department of Oncology and Nuclear Medicine, University Hospital Center Sestre Milosrdnice, Zagreb, Croatia.
  • Savas H; Department of Radiology, University of Michigan, Ann Arbor, Michigan.
  • Youssef E; Department of Radiology, University of Michigan, Ann Arbor, Michigan.
  • Regan D; Department of Radiology, University of Michigan, Ann Arbor, Michigan.
  • Wilderman SJ; Department of Nuclear Engineering, University of Michigan, Ann Arbor, Michigan; and.
  • Roberson PL; Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
  • Kaminski MS; Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.
  • Avram AM; Department of Radiology, University of Michigan, Ann Arbor, Michigan.
J Nucl Med ; 55(7): 1047-53, 2014 Jul.
Article in En | MEDLINE | ID: mdl-24842891

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Radiation Dosage / Lymphoma, Non-Hodgkin / Radioimmunotherapy / Precision Medicine / Antibodies, Monoclonal Type of study: Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Nucl Med Year: 2014 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 Database: MEDLINE Main subject: Radiation Dosage / Lymphoma, Non-Hodgkin / Radioimmunotherapy / Precision Medicine / Antibodies, Monoclonal Type of study: Guideline / Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Nucl Med Year: 2014 Document type: Article